Measurements and management of multiple sclerosis-related fatigue: an umbrella review and meta-analysis.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 42553000.
- Also identified by DOI 10.1080/09638288.2026.2711882.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aims to synthesize and appraise systematic reviews with meta-analyses that assessed pharmacological, non-pharmacological, and neuromodulatory interventions for MS-related fatigue. PubMed, WOS, Scopus, Epistemonikos, and the Cochrane Database of Systematic Reviews were searched till Nov 2025. Effect sizes are reported as standardized mean differences (SMDs) with 95% confidence intervals (CIs). Methodological quality was graded with AMSTAR-2. An exploratory meta-meta-analysis was also performed. Forty-six systematic reviews with meta-analyses covering 287 primary studies were included. Exercise provided the most consistent benefit: aerobic training produced a modest but reliable reduction in fatigue (SMD -0.32), while resistance exercise (-1.09) and yoga/mind-body formats (-0.70) showed larger but more heterogeneous effects. Cognitive behavioral therapy (CBT) and mindfulness/acceptance therapies yielded small to moderate improvements, while energy-conservation education showed a modest benefit. Vitamin D supplementation yielded a small effect (-0.18). Among neuromodulation approaches, transcranial direct current stimulation demonstrated a significant short-term impact (-1.02). Structured exercise supported by CBT or mindfulness offers the most clinically meaningful relief from MS-related fatigue. Future RCTs should adopt longer follow-up, and use standardized outcome fatigue scales. These conclusions should be interpreted considering the generally low methodological quality of the included reviews.